Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly ...
Moderna is up 20% YTD, with a golden cross suggesting a trend reversal. Momentum indicators make it a top 2026 pick.
Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...
Every winter, Austin gets walloped by cedar fever: runny noses, scratchy throats, watering eyes, and canceled plans as ...
Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...
MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.
Live Science on MSN
An experimental mRNA treatment counters immune cell aging in mice
A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds. A new ...
The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, ...
Researchers found a way to boost aging immune systems by turning the liver into a temporary source of immune support signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results